MFAT After an Injury: Innovative Treatment Options

When Is MFAT Recommended After an Auto or Work Injury?

Abstract

Motor vehicle accidents and workplace injuries can damage joints, cartilage, tendons, ligaments, muscles, and other soft tissues. Many injuries improve with rest, chiropractic care, physical rehabilitation, activity changes, and basic injection treatments. However, some injuries are more complex or heal very slowly.

Microfragmented adipose tissue, or MFAT, may be considered for moderate or advanced joint damage, cartilage injury, a larger partial tendon or ligament tear, or symptoms that continue after conservative care. MFAT uses a small amount of the patient’s own fat tissue to create a supportive biological product that is placed into an injured area.

This article explains when MFAT may be recommended after an auto accident or work injury, how it differs from platelet-rich plasma, when it may not be appropriate, and how it can fit into a coordinated plan that includes integrative chiropractic care, rehabilitation, functional medicine, and medical oversight.

What Is Microfragmented Adipose Tissue?

Microfragmented adipose tissue is made from a small amount of the patient’s own fat. The fat is often collected from the abdomen, side, or thigh through a small lipoaspiration procedure.

The tissue is then:

• Washed in a sterile system
• Broken into very small fragments
• Cleared of unwanted fluid and debris
• Prepared for injection
• Placed into the injured joint or soft tissue

MFAT keeps parts of the fat’s natural structure, including its supporting matrix and biological signaling components. It differs from laboratory-grown stem cell treatment because the tissue is usually processed and used during the same visit, without cell expansion.

University of Iowa Health Care describes MFAT as a nonsurgical procedure that uses a patient’s own adipose tissue. The processed tissue may provide cushioning and biological support inside damaged joints or around certain tendon injuries (University of Iowa Health Care, n.d.).

MFAT should not be described as a guaranteed way to regrow cartilage, rebuild a torn ligament, or cure arthritis. Its main goal is to create a healthier environment around the injured tissue, reduce irritation, support function, and possibly help the body’s normal healing response.

When Is MFAT Recommended for Personal Injuries?

MFAT is usually not the first treatment recommended after a motor vehicle accident or workplace injury. Most people begin with less invasive care.

Early treatment may include:

• Activity changes
• Chiropractic care
• Physical rehabilitation
• Home exercises
• Soft-tissue treatment
• Bracing
• Anti-inflammatory lifestyle support
• Platelet-rich plasma when appropriate

MFAT may be discussed when an injury is more complex, involves a larger amount of tissue damage, or has not improved enough with simpler care.

Moderate to Severe Post-Traumatic Joint Degeneration

A hard impact can injure the cartilage and other structures inside a joint. For example, a knee may strike the dashboard during a collision, or a worker may twist a knee while carrying a heavy object.

The original injury can cause inflammation, joint instability, meniscus damage, and uneven pressure on the cartilage. Over time, these problems may lead to post-traumatic osteoarthritis.

MFAT may be considered when the patient has:

• Moderate joint degeneration
• Ongoing joint swelling or stiffness
• Pain with walking, lifting, or climbing stairs
• Cartilage wear seen on imaging
• Loss of function despite rehabilitation
• Limited improvement after PRP or other injections

Several clinical sources describe MFAT as a possible option for patients with persistent osteoarthritis symptoms or moderate joint damage, especially after standard treatments have not provided enough improvement (Close, 2026; Kanaan, 2026; Sellers, 2025).

Research has found that MFAT may improve pain and function in some patients with knee osteoarthritis. However, recent reviews also report that MFAT may not provide better results than PRP or bone marrow concentrate for every patient. This means treatment selection should be based on the individual injury rather than the idea that MFAT is always the strongest option (Hohmann et al., 2025a, 2025b; Ye et al., 2024).

Larger Partial Tendon Tears

Tendons connect muscles to bones. They can be damaged when the body is suddenly pulled, twisted, or forced beyond its normal range.

Accident-related examples include:

• Partial rotator cuff tears
• Partial Achilles tendon tears
• Patellar tendon injuries
• Hamstring tendon injuries
• Gluteal tendon injuries
• Chronic elbow tendon damage

Smaller tendon injuries may respond to rehabilitation, load management, or PRP. MFAT may be considered for a larger partial tear, chronic degeneration, or an injury that has not improved after an appropriate rehabilitation program.

Clinical sources describe partial rotator cuff tears, Achilles problems, chronic tendon degeneration, and significant tendon damage as possible MFAT applications. However, the clinical evidence for tendon injuries is less developed than the evidence for knee osteoarthritis (Palm Beach Regenerative Sport & Spine, n.d.; University of Iowa Health Care, n.d.).

A complete tendon rupture may still require a surgical consultation. MFAT should not delay surgery when the tendon is fully torn, the muscle has lost function, or the tissue has pulled far away from its normal attachment.

Larger Partial Ligament Injuries

Ligaments connect one bone to another and help stabilize joints. A crash, fall, or sudden workplace twist can stretch or partially tear a ligament.

MFAT may be considered when:

• The ligament has a larger partial tear
• The joint remains unstable
• The injury is healing slowly
• Rehabilitation has not restored function
• PRP has produced limited improvement
• Surgery is not immediately required

The treatment plan must also address the cause of continued stress on the ligament. An injection cannot correct poor balance, weak stabilizing muscles, restricted joint motion, or unsafe lifting mechanics by itself.

Cartilage Defects and Meniscus-Related Problems

Cartilage has a limited blood supply, which can make it difficult to heal. A traumatic cartilage defect may occur in the knee, hip, shoulder, ankle, or another joint.

MFAT may be discussed when imaging shows:

• A focal cartilage defect
• Degenerative meniscus changes
• Post-traumatic cartilage wear
• Joint surface damage
• Continued pain during weight-bearing activities
• Loss of function despite conservative treatment

The fat tissue may provide a supportive matrix and cushioning effect within the joint. However, it should not be presented as a proven replacement for missing cartilage. More research is needed to determine whether MFAT changes the long-term structure of damaged joints.

When Is PRP Usually Tried Before MFAT?

Platelet-rich plasma, or PRP, is made from the patient’s own blood. It contains concentrated platelets and growth factors that may support the healing response.

PRP may be considered first for:

• Mild to moderate joint degeneration
• Tendinitis
• Tendon irritation
• Smaller partial tears
• Mild ligament injuries
• Early cartilage wear
• Injuries that have not yet received injection treatment

PRP requires a blood draw, while MFAT requires the removal of a small amount of fat. MFAT is therefore more involved and may cause temporary soreness or bruising at both the harvest site and injection site.

Some providers consider MFAT after PRP has failed to return enough function. Others may recommend MFAT earlier when imaging shows a more advanced injury. Recent comparisons suggest that MFAT and PRP may produce similar results for many patients with knee osteoarthritis, so the more invasive treatment is not automatically the better option (Hohmann et al., 2025b; Ye et al., 2024).

Who May Not Be a Good MFAT Candidate?

A full evaluation is needed before MFAT is recommended. The clinician should review the patient’s health history, medications, examination findings, imaging, goals, and previous treatment.

MFAT may not be appropriate when a patient has:

• An active infection
• An uncontrolled bleeding disorder
• Serious uncontrolled medical conditions
• A complete tendon or ligament rupture
• Severe joint deformity
• Major mechanical instability
• A fracture that has not been treated
• A condition requiring urgent surgery
• Unrealistic expectations
• Symptoms that do not match the imaging findings

Patients taking blood thinners or living with diabetes, immune disorders, cardiovascular disease, or poor wound healing may need added medical screening.

The U.S. Food and Drug Administration states that regenerative medicine therapies have not been approved as treatments for orthopedic conditions such as osteoarthritis, tendonitis, back pain, or knee pain. A device used to collect or process tissue may have FDA clearance, but that does not mean the resulting orthopedic treatment is FDA-approved. Patients should receive clear information about evidence, risks, alternatives, costs, and regulatory status before agreeing to treatment (U.S. Food and Drug Administration, 2021).

How Integrative Chiropractic Care Fits With MFAT

MFAT focuses on the biological environment of an injured tissue. Integrative chiropractic care focuses on movement, joint mechanics, muscle control, posture, and physical function.

These approaches do different jobs.

Chiropractic and rehabilitation care may help:

• Improve comfortable joint motion
• Reduce unnecessary mechanical stress
• Address muscle guarding
• Improve posture and movement patterns
• Restore balance and coordination
• Rebuild joint stability
• Prepare the patient to return to work
• Track functional progress

The care must be properly timed. Immediately after an MFAT procedure, the treated tissue may need protection and gentle movement. High-force treatment, heavy exercise, deep pressure over the injection site, and rapid return to demanding activity may not be appropriate.

As healing progresses, the plan may move through several stages:

1. Protection: Control load and protect the treated area.
2. Mobility: Begin gentle, approved range-of-motion exercises.
3. Stability: Improve muscle control around the joint.
4. Strength: Increase resistance without overloading the tissue.
5. Function: Practice job duties, walking, lifting, or sports movements.
6. Prevention: Correct movement problems that could cause reinjury.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, has observed in his clinical work that injection procedures should not stand alone. His approach connects imaging and examination findings with joint movement, nerve function, rehabilitation, nutrition, and measurable daily activities. The goal is to support biological recovery while correcting movement patterns that may continue to overload the injured area (Jimenez, n.d.; ChiroMed, 2026).

These observations represent a clinical approach and should not be confused with proof that chiropractic adjustments make MFAT more effective. The combined plan is designed to address different parts of the recovery process.

Medical Oversight at Injury Medical Clinic PA

At Injury Medical Clinic PA in El Paso, Texas, Dr. Jimenez works with Dr. Maria Guadalupe Cardenas, MD, who is identified by clinic materials as Board Certified in Internal Medicine, Medical Director, and Collaborative Physician.

Dr. Cardenas has been an internist for more than 40 years. Public provider records identify her Texas medical license as J2933 and her NPI as 1164426748. Some clinic pages display 1164426749, but public provider listings identify 1164426748 as the valid NPI.

This multidisciplinary arrangement allows the team to combine:

• Medical evaluation and oversight
• Integrative chiropractic care
• Functional medicine
• Personal injury care
• Imaging and laboratory review
• Physical rehabilitation
• Return-to-work planning
• Progress examinations
• Referrals when surgery or specialty care is needed

Dr. Cardenas’s internal medicine background can help the team review medical conditions, medications, infection risks, bleeding risks, cardiovascular concerns, diabetes, and other factors that may affect healing. Dr. Jimenez focuses on musculoskeletal evaluation, chiropractic care, functional recovery, rehabilitation, and injury documentation.

This type of coordinated model can be useful because a personal injury often affects more than one tissue. A patient may have joint damage, muscle guarding, nerve symptoms, poor sleep, reduced activity, inflammation, and health conditions that slow recovery.

A Careful Decision Is More Important Than a Stronger Injection

MFAT may be recommended for selected patients with moderate or advanced joint injury, cartilage damage, larger partial tendon or ligament tears, or slow-to-heal conditions that have not improved enough with conservative care.

It is not automatically the next step after every accident. A proper recommendation depends on:

• The exact diagnosis
• Injury severity
• Imaging results
• Previous treatment
• Joint stability
• Overall health
• Functional limitations
• Patient goals
• Available evidence
• Whether surgery is more appropriate

For the right patient, MFAT may become one part of a broader recovery plan. Medical oversight helps screen for risk. Chiropractic care and rehabilitation address movement and strength. Functional medicine may address nutrition, sleep, inflammation, and other health factors.

The best goal is not simply to receive an advanced injection. The goal is to select the safest treatment, protect the healing tissue, restore function, and help the patient return to work and normal daily life.

---

References

ChiroMed. (2026). Regenerative therapy for auto accident injury recovery.

Close, M. (2026, February 26). Comparing PRP, BMAC, and MFAT: Choosing the right regenerative treatment. Sports Medicine of the Rockies.

Health Coach Clinic. (n.d.). Regenerative options for injury recovery explained.

Hohmann, E., Keough, N., Frank, R. M., & Rodeo, S. A. (2025a). Microfragmented adipose tissue has no advantage over platelet-rich plasma and bone marrow aspirate injections for symptomatic knee osteoarthritis: A systematic review and meta-analysis. The American Journal of Sports Medicine.

Hohmann, E., et al. (2025b). Micro-fragmented adipose tissue demonstrates comparable clinical efficacy to other orthobiologic injections in treating symptomatic knee osteoarthritis: A systematic review of Level I to IV clinical studies. Arthroscopy, 41(2), 418–441.e14.

Jimenez, A. (n.d.). Dr. Alex Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN.

Kanaan, M. (2026, March 9). PRP vs. MFAT cell therapy: Which regenerative treatment is right for you?. Carolina Nonsurgical Orthopedics.

Palm Beach Regenerative Sport & Spine. (n.d.). Microfragmented adipose tissue—MFAT.

Sellers, T. (2025, November 3). Micro-fragmented adipose tissue: A breakthrough treatment for knee arthritis. Sellers Sports Medicine and Family Practice.

University of Iowa Health Care. (n.d.). Microfragmented adipose tissue—MFAT.

U.S. Food and Drug Administration. (2021, June 3). Important patient and consumer information about regenerative medicine therapies.

Ye, X., Shen, Z., Li, X., Zhang, B., Shen, G., & Wu, L. (2024). Microfragmented adipose tissue versus platelet-rich plasma in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Acta Orthopaedica Belgica, 90(3).